The detection of (total and ccc) HBV DNA in liver transplant recipients with hepatitis B vaccine against HBV reinfection

References

• European Association For The Study Of The Liver. EASL clinical practice guidelines: management of chronic hepatitis B virus infection. J Hepatol 2012; 57(1):167-85; PMID:22436845; http://dx.doi.org/10.1016/j.jhep.2012.02.010
   PubMed Web of Science ®Google Scholar
• Kim WR, Poterucha JJ, Kremers WK, Ishitani MB, Dickson ER. Outcome of liver transplantation for hepatitis B in the United States. Liver Transpl 2004; 10(8):968-74; PMID:15390321; http://dx.doi.org/10.1002/lt.20217
   PubMed Web of Science ®Google Scholar
• Steinmuller T, Seehofer D, Rayes N, Müller AR, Settmacher U, Jonas S, Neuhaus R, Berg T, Hopf U, Neuhaus P. Increasing applicability of liver transplantation for patients with hepatitis B-related liver disease. Hepatology 2002; 35(6):1528-35; PMID:12029640; http://dx.doi.org/10.1053/jhep.2002.33681
   PubMed Web of Science ®Google Scholar
• Roche B, Samuel D. Prevention of hepatitis B virus reinfection in liver transplant recipients. Intervirology 2014; 57(3-4):196-201; PMID:25034488; http://dx.doi.org/10.1159/000360944
   PubMed Web of Science ®Google Scholar
• Croagh CM, Desmond PV, Bell SJ. Genotypes and viral variants in chronic hepatitis B: a review of epidemiology and clinical relevance. World J Hepatol 2015; 7(3):289-303; PMID:25848459; http://dx.doi.org/10.4254/wjh.v7.i3.289
   PubMedGoogle Scholar
• Cholongitas E, Goulis J, Akriviadis E, Papatheodoridis GV. Hepatitis B immunoglobulin and/or nucleos(t)ide analogues for prophylaxis against hepatitis b virus recurrence after liver transplantation: a systematic review. Liver Transpl 2011; 17(10):1176-90; PMID:21656655; http://dx.doi.org/10.1002/lt.22354
   PubMed Web of Science ®Google Scholar
• Dan YY, Wai CT, Yeoh KG, Lim SG. Prophylactic strategies for hepatitis B patients undergoing liver transplant: a cost-effectiveness analysis. Liver Transpl 2006; 12(5):736-46; PMID:16628682; http://dx.doi.org/10.1002/lt.20685
   PubMed Web of Science ®Google Scholar
• Hussain M, Soldevila-Pico C, Emre S, Luketic V, Lok AS; NIH HBV-OLT Study Group. Presence of intrahepatic (Total and ccc) HBV DNA is not predictive of HBV recurrence after liver transplantation. Liver Trans 2007; 13(8):1137-1144; PMID:17663390; http://dx.doi.org/10.1002/lt.21179
   PubMed Web of Science ®Google Scholar
• Lenci I, Marcuccilli F, Tisone G, Di Paolo D, Tariciotti L, Ciotti M, Guenci T, Perno CF, Angelico M. Total and covalently closed circular DNA detection in liver tissue of long-term survivors transplanted for HBV-related cirrhosis. Digest Liver Dis 2010; 42(8):578-584; PMID:20097143; http://dx.doi.org/10.1016/j.dld.2009.12.003
   PubMed Web of Science ®Google Scholar
• Coffin CS, Mulrooney-Cousins PM, van Marle G, Roberts JP, Michalak TI, Terrault NA. Hepatitis B virus quasispecies in hepatic and extrahepatic viral reservoirs in liver transplant recipients on prophylactic therapy. Liver Tran 2011; 17(8):955-962; PMID:21462295; http://dx.doi.org/10.1002/lt.22312
   PubMed Web of Science ®Google Scholar
• Roche B, Feray C, Gigou M, Roque-Afonso AM, Arulnaden JL, Delvart V, Dussaix E, Guettier C, Bismuth H, Samuel D. HBV DNA persistence 10 years after liver transplantation despite successful anti-HBS passive immunoprophylaxis. Hepatology 2003; 38(1):86-95; PMID:12829990; http://dx.doi.org/10.1053/jhep.2003.50294
   PubMed Web of Science ®Google Scholar
• Sanchez-Fueyo A, Rimola A, Grande L, Costa J, Mas A, Navasa M, Cirera I, Sánchez-Tapias JM, Rodés J. Hepatitis B immunoglobulin discontinuation followed by hepatitis B virus vaccination: a new strategy in the prophylaxis of hepatitis B virus recurrence after liver transplantation. Hepatology 2000; 31(2):496-501; PMID:10655276; http://dx.doi.org/10.1002/hep.510310233
   PubMed Web of Science ®Google Scholar
• Angelico M, Di Paolo D, Trinito MO, Petrolati A, Araco A, Zazza S, Lionetti R, Casciani CU, Tisone G. Failure of a reinforced triple course of hepatitis B vaccination in patients transplanted for HBV-related cirrhosis. Hepatology 2002; 35(1):176-81; PMID:11786974; http://dx.doi.org/10.1053/jhep.2002.30278
   PubMed Web of Science ®Google Scholar
• Lo CM, Liu CL, Chan SC, Lau GK, Fan ST. Failure of hepatitis B vaccination in patients receiving lamivudine prophylaxis after liver transplantation for chronic hepatitis B. J Hepatol 2005; 43(2):283-7; PMID:15964658; http://dx.doi.org/10.1016/j.jhep.2005.03.013
   PubMed Web of Science ®Google Scholar
• Rosenau J, Hooman N, Hadem J, Rifai K, Bahr MJ, Philipp G, Tillmann HL, Klempnauer J, Strassburg CP, Manns MP. Failure of hepatitis B vaccination with conventional HBsAg vaccine in patients with continuous HBIG prophylaxis after liver transplantation. Liver Transpl 2007; 13(3):367-73; PMID:17318859; http://dx.doi.org/10.1002/lt.21003
   PubMed Web of Science ®Google Scholar
• Bienzle U, Günther M, Neuhaus R, Vandepapeliere P, Vollmar J, Lun A, Neuhaus P. Immunization with an adjuvant hepatitis B vaccine after liver transplantation for hepatitis B-related disease. Hepatology 2003; 38(4):811-9; PMID:14512868
   PubMed Web of Science ®Google Scholar
• Starkel P, Stoffel M, Lerut J, Horsmans Y. Response to an experimental HBV vaccine permits withdrawal of HBIg prophylaxis in fulminant and selected chronic HBV-infected liver graft recipients. Liver Transpl 2005; 11(10):1228-34; PMID:16184571; http://dx.doi.org/10.1002/lt.20464
   PubMed Web of Science ®Google Scholar
• Rosenau J, Hooman N, Rifai K, Solga T, Tillmann HL, Grzegowski E, Nashan B, Klempnauer J, Strassburg CP, Wedemeyer H, et al. Hepatitis B virus immunization with an adjuvant containing vaccine after liver transplantation for hepatitis B-related disease: failure of humoral and cellular immune response. Transpl Int 2006; 19(10):828-33; PMID:16961775; http://dx.doi.org/10.1111/j.1432-2277.2006.00374.x
   PubMed Web of Science ®Google Scholar
• Tahara H, Tanaka Y, Ishiyama K, Ide K, Shishida M, Irei T, Ushitora Y, Ohira M, Banshodani M, Tashiro H, et al. Successful hepatitis B vaccination in liver transplant recipients with donor-specific hyporesponsiveness. Transpl Int 2009; 22(8):805-13; PMID:19490542; http://dx.doi.org/10.1111/j.1432-2277.2009.00864.x
   PubMed Web of Science ®Google Scholar
• Di Paolo D, Lenci I, Cerocchi C, Tariciotti L, Monaco A, Brega A, Lotti L, Tisone G, Angelico M. One-year vaccination against hepatitis B virus with a MPL-vaccine in liver transplant patients for HBV-related cirrhosis. Transpl Int 2010; 23(11):1105-12; PMID:20492620; http://dx.doi.org/10.1111/j.1432-2277.2010.01104.x
   PubMed Web of Science ®Google Scholar
• Weber NK, Forman LM, Trotter JF. HBIg discontinuation with maintenance oral anti-viral therapy and HBV vaccination in liver transplant recipients. Dig Dis Sci 2010; 55(2):505-9; PMID:19802696; http://dx.doi.org/10.1007/s10620-009-0999-6
   PubMed Web of Science ®Google Scholar
• Rimola A, Sanchez-Fueyo A. Hepatitis B vaccination after liver transplantation as a strategy to discontinue prophylaxis with hepatitis B immune globulin. J Hepatol 2004; 40(4):722-4; PMID:15030998; http://dx.doi.org/10.1016/j.jhep.2004.02.014
   PubMed Web of Science ®Google Scholar
• Shi-Chun Lu, Tao Jiang, Wei Lai, Yuan Liu, Jing Zhang, Dao-Bing Zeng, Chuan-Yun Li, Meng-Long Wang, Dong-Dong Lin, Yue-Zhu, et al. Reestablishment of active immunity against HBV graft reinfection after liver transplantation for HBV-related end stage liver disease. J Immunol Res 2014; 2014:1-9; http://dx.doi.org/10.1155/2014/492849
   Google Scholar
• Wang M, Qiu N, Lu S, Xiu D, Yu J, Wang XT, Lu F, Li T, Liu X, Zhuang H. Serum hepatitis B surface antigen is correlated with intrahepatic total HBV DNA and cccDNA in treatment-naive patients with chronic hepatitis B but not in patients with HBV related hepatocellular carcinoma. J Med Virol 2012; 85(2):219-27; PMID:23168998; http://dx.doi.org/10.1002/jmv.23461
   PubMed Web of Science ®Google Scholar